Clinical Trial Update: PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating PPSV23 pneumococcal vaccine in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PPSV23 Pneumococcal Vaccine (pneumococcal polysaccharide vaccine, 23-valent)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED